- Trials with a EudraCT protocol (38)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
38 result(s) found for: topical neuropathic.
Displaying page 1 of 2.
EudraCT Number: 2008-001684-11 | Sponsor Protocol Number: mentholmarch08 | Start Date*: 2008-06-19 | |||||||||||
Sponsor Name:University of Edinburgh | |||||||||||||
Full Title: A Pilot Study into the Effect of Topical Menthol for Patients with Neuropathic-Type Pain. | |||||||||||||
Medical condition: The condition under investigation is neuropathic-type pain. This may be due to a variety of causes including malignant neuropathic-type pain (such as tumour-related nerve compression or cancer-rel... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003077-26 | Sponsor Protocol Number: IMIVER | Start Date*: 2012-08-13 | |||||||||||
Sponsor Name:Department of Neurology, Odense University Hospital | |||||||||||||
Full Title: Topical lidocaine for the treatment of focal peripheral neuropathic pain: response in relation to pain phenotype | |||||||||||||
Medical condition: Chronic peripheral neuropathic pain caused by postherpetic neuralgia and traumatic/surgical nerve injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023258-34 | Sponsor Protocol Number: QTZ-EC-0002 | Start Date*: 2011-05-02 | |||||||||||
Sponsor Name:Astellas Pharma Europe Ltd. | |||||||||||||
Full Title: Tolerability of QUTENZA(TM) when applied after pre-treatment with lidocaine or tramadol in subjects with peripheral neuropathic pain – A randomized, multi-center, assessor-blinded study | |||||||||||||
Medical condition: Documented diagnosis at the Treatment Visit of either: •PHN with pain persisting at least 3 months since shingles vesicle crusting, or •Post-traumatic Peripheral Neuropathic Pain syndrome, includin... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) CZ (Completed) IE (Completed) BE (Completed) GB (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002846-21 | Sponsor Protocol Number: PARENTIDE-02 | Start Date*: 2017-04-10 |
Sponsor Name:BCN Peptides S.A. | ||
Full Title: CLINICAL TRIAL PHASE IIa PROOF OF CONCEPT, DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED IN PATIENTS WITH NEUROPATHIC PAIN DUE TO PERIPHERAL NERVE INJURY | ||
Medical condition: Patients with neuropathic pain due to peripheral nerve injury | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2018-003617-17 | Sponsor Protocol Number: NCT03348735 | Start Date*: 2018-12-03 |
Sponsor Name:Antwerp University Hospital (UZA) | ||
Full Title: Efficacy, patient acceptability and safety of topical treatment versus systemic treatment: a randomized, multicenter, comparative pragmatic trial in adult patients suffering from diverse localized ... | ||
Medical condition: Patients suffering from localized neuropathic pain (LNP) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010091-17 | Sponsor Protocol Number: KIP112967 | Start Date*: 2009-09-15 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from peripheral nerve injury. Estudio aleatorizado, do... | |||||||||||||
Medical condition: Neuropathic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) SE (Completed) DK (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015415-41 | Sponsor Protocol Number: 2009002 | Start Date*: 2010-04-16 |
Sponsor Name:Universitair Ziekenhuis Antwerpen (UZA) - Multidisciplinair Pijncentrum | ||
Full Title: Lidocaine patches in postoperative and posttraumatic neuropathic chronic skin pain - A prospective, randomized, double-blinded, placebo-controlled, parrallel, multicentre, investigator initiated st... | ||
Medical condition: Patients with postoperative or posttraumatic neuropathic chronic cutaneous pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-016337-10 | Sponsor Protocol Number: KF10004/08 | Start Date*: 2010-04-26 | ||||||||||||||||
Sponsor Name:Grünenthal GmbH | ||||||||||||||||||
Full Title: Lidocaine 5% medicated plaster for the topical treatment of localized chronic postoperative neuropathic pain after total knee replacement or thoracotomy | ||||||||||||||||||
Medical condition: localized chronic post-operative neuropathic pain (PoNP) after total knee replacement or thoracotomy (including drainage, excluding subjects with neoplasia-related thoracotomy) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-002266-71 | Sponsor Protocol Number: GN14RE146 | Start Date*: 2015-01-02 | |||||||||||
Sponsor Name:NHS Greater Glasgow and Clyde | |||||||||||||
Full Title: The role of Qutenza (topical capsaicin 8%) in treating neuropathic pain from arteriovenous fistulae in patients with end stage renal failure | |||||||||||||
Medical condition: Chronic neuropathic pain from arteriovenous fistulae in patients with end stage renal failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003968-31 | Sponsor Protocol Number: | Start Date*: 2014-04-09 | |||||||||||
Sponsor Name:University of Edinburgh (ACCORD) [...] | |||||||||||||
Full Title: A phase II RCT of topical menthol gel versus placebo in the treatment of chemotherapy induced peripheral neuropathic pain | |||||||||||||
Medical condition: Chemotherapy Induced Peripheral Neuropathy (CIPN) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-007478-39 | Sponsor Protocol Number: 42160443NPP2001 | Start Date*: 2009-10-07 | |||||||||||||||||||||
Sponsor Name:Janssen Cilag International, NV | |||||||||||||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Subjects With Postherpetic Neuralgia and Post-T... | |||||||||||||||||||||||
Medical condition: Postherpetic Neuralgia and Post-Traumatic Neuralgia | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: BE (Completed) NL (Prematurely Ended) ES (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-003502-28 | Sponsor Protocol Number: AP-325.04 | Start Date*: 2020-02-14 | |||||||||||
Sponsor Name:Algiax Pharmaceuticals GmbH | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AP-325 in Subjects with Peripheral Post-surgical Neuropathic Pain | |||||||||||||
Medical condition: Peripheral post-surgical neuropathic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) CZ (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001587-30 | Sponsor Protocol Number: GU11SU387 | Start Date*: 2013-09-26 | ||||||||||||||||
Sponsor Name:NHS Greater Glasgow and Clyde | ||||||||||||||||||
Full Title: The role of pre-emptive analgesia with Qutenza (topical capsaicin 8%) in preventing neuropathic pain following lower limb amputation: a pilot randomised controlled study | ||||||||||||||||||
Medical condition: Chronic neuropathic pain following limb amputation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-000692-15 | Sponsor Protocol Number: 05-DFU-001 | Start Date*: 2006-05-03 |
Sponsor Name:Intercytex | ||
Full Title: A prospective single centre, open label, pilot study to evaluate the safety of ICXP007 plus standard of care, for the treatment of lower extremity chronic, neuropathic diabetic foot ulcers | ||
Medical condition: Diabetic foot ulcers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004535-40 | Sponsor Protocol Number: 0189/DEV | Start Date*: 2015-04-22 | |||||||||||
Sponsor Name:Develco Pharma Schweiz AG | |||||||||||||
Full Title: Prospective, single-blind, placebo-controlled, three-treatment, three-period, adaptive multi-centre Phase IIa (proof-of-concept) trial to investigate the efficacy, safety, and tolerability of Ketam... | |||||||||||||
Medical condition: Chronic non-malignant neuropathic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003739-32 | Sponsor Protocol Number: 2PX-PHN-01 | Start Date*: 2005-12-23 |
Sponsor Name:Santosolve A/S | ||
Full Title: A double-blind, placebo-controlled, enriched enrolment, randomised withdrawal study to evaluate the efficacy and safety of 2PX in patients with neuropathic pain due to post-herpetic neuralgia | ||
Medical condition: Patients suffering from pain due to post-herpetic neuralgia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012836-33 | Sponsor Protocol Number: KIP113049 | Start Date*: 2009-11-26 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from lumbosacral radiculopathy | |||||||||||||
Medical condition: Neuropathic pain from lumbosacral radiculopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DE (Completed) DK (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003132-29 | Sponsor Protocol Number: KF10004/03 | Start Date*: 2007-01-10 | |||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||
Full Title: Safety and efficacy of lidocaine 5% medicated plaster in comparison with pregabalin in postherpetic neuralgia and diabetic polyneuropathic pain | |||||||||||||
Medical condition: postherpetic neuralgia and painful diabetic polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) SI (Completed) BE (Completed) CZ (Completed) AT (Completed) SE (Completed) DE (Completed) PT (Completed) IT (Completed) GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001409-64 | Sponsor Protocol Number: AV001 | Start Date*: 2021-09-16 | |||||||||||
Sponsor Name:Averitas Pharma, Inc. | |||||||||||||
Full Title: An interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial evaluating the efficacy and safety of Qutenza® in subjects with post-surgical neuropat... | |||||||||||||
Medical condition: Post-surgical neuropathic pain (PSNP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) NL (Ongoing) PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001586-32 | Sponsor Protocol Number: GN12RE072 | Start Date*: 2012-12-13 | |||||||||||
Sponsor Name:NHS Greater Glasgow and Clyde | |||||||||||||
Full Title: The role of Qutenza (topical capsaicin 8%) in the treatment of chronic pain from critical ischaemia in patients with end stage renal failure | |||||||||||||
Medical condition: Chronic pain from critical limb ischaemia in patients with end-stage renal failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.